This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Vertex Pharmaceuticals, Inc.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Innovations by James C Sullivan
Introduction
James C Sullivan is an accomplished inventor based in Sudbury, MA (US). He has made significant contributions to the field of biotechnology, particularly in the area of viral amplification techniques. His work has implications for the diagnosis and treatment of hepatitis C, a virus that affects millions worldwide.
Latest Patents
James C Sullivan holds a patent for "Methods for amplifying hepatitis C virus nucleic acids." This innovative method involves amplifying a segment of a DNA template that is complementary to the genome of HCV RNA from an infected sample. The process utilizes a two-stage PCR, employing specific outer and inner primers to enhance the accuracy and efficiency of the amplification. This patent represents a crucial advancement in the field of molecular diagnostics.
Career Highlights
Sullivan is currently associated with Vertex Pharmaceuticals, Inc., a leading biotechnology company known for its focus on innovative therapies. His work at Vertex has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry. With a total of 1 patent, his contributions are recognized within the scientific community.
Collaborations
Throughout his career, James has collaborated with notable colleagues, including Benjamin Shames and James Daniel Frantz. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
James C Sullivan's work exemplifies the spirit of innovation in biotechnology. His patented methods for amplifying hepatitis C virus nucleic acids are a testament to his dedication to improving healthcare outcomes. His contributions continue to influence the field and inspire future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
